Literature DB >> 26450843

Characterization of mild and severe post-radical nephrectomy renal functional deterioration utilizing histopathological evaluation of non-neoplastic nephrectomized renal parenchyma.

Takehiro Sejima1, Tetsuya Yumioka2, Noriya Yamaguchi2, Hideto Iwamoto2, Toshihiko Masago2, Shuichi Morizane2, Masashi Honda2, Atsushi Takenaka2.   

Abstract

BACKGROUND: We investigated factors affecting mild (MRFD) and severe renal functional deterioration (SRFD) after radical nephrectomy with a special focus on the histopathology of nephrectomized non-neoplastic renal parenchyma.
METHODS: MRFD was defined as a postoperative decline of percent estimated glomerular filtration rate (eGFR) lower than the value of the mean minus standard deviation (SD). SRFD was defined as a rate greater than the value of the mean plus SD. The histopathological factors of global glomerulosclerosis (GS) and arteriosclerosis in non-neoplastic renal parenchyma and multiple clinical factors were analyzed to determine whether they affected postoperative renal functional deterioration in 100 renal cell carcinoma cases. The prognoses, including non-cancer mortality, were collected from long-term follow-up data.
RESULTS: A higher preoperative eGFR and a higher global GS extent in non-neoplastic renal parenchyma were independently associated with MRFD and SRFD, respectively. The cardiovascular disease-specific survival rates of the SRFD group and the group with global GS extent >14 % were significantly worse than those of their counterparts.
CONCLUSIONS: This is the first report to identify global GS extent in nephrectomized non-neoplastic renal parenchyma as a factor affecting the development of life-threatening post-nephrectomy renal functional deterioration. Moreover, we are the first to advocate the importance of the characterization of favorable post-nephrectomy renal functional deterioration. The identification of MRFD and SRFD by histopathological evaluation of nephrectomized non-neoplastic renal parenchyma will contribute to personalized postoperative follow-up. It may improve follow-up of individual patients with SRFD by permitting collaboration with other clinical departments such as cardiology.

Entities:  

Keywords:  Cardiovascular disease; Chronic kidney disease; Global glomerulosclerosis; Radical nephrectomy; Renal parenchymal histopathology

Mesh:

Year:  2015        PMID: 26450843     DOI: 10.1007/s10147-015-0909-1

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  22 in total

1.  Elective partial nephrectomy in patients with clinical T1b renal tumors is associated with improved overall survival.

Authors:  Christopher J Weight; Benjamin T Larson; Tianming Gao; Steven C Campbell; Brian R Lane; Jihad H Kaouk; Inderbir S Gill; Eric A Klein; Amr F Fergany
Journal:  Urology       Date:  2010-05-10       Impact factor: 2.649

2.  Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter.

Authors:  Mesut Remzi; Mehmet Ozsoy; Hans-Christoph Klingler; Martin Susani; Matthias Waldert; Christian Seitz; Joerg Schmidbauer; Michael Marberger
Journal:  J Urol       Date:  2006-09       Impact factor: 7.450

Review 3.  The non-neoplastic kidney in tumor nephrectomy specimens: what can it show and what is important?

Authors:  Stephen M Bonsib; Ying Pei
Journal:  Adv Anat Pathol       Date:  2010-07       Impact factor: 3.875

4.  Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure.

Authors:  Vanesa Bijol; Gonzalo P Mendez; Shelley Hurwitz; Helmut G Rennke; Vânia Nosé
Journal:  Am J Surg Pathol       Date:  2006-05       Impact factor: 6.394

5.  Histopathological predictors of renal function decrease after laparoscopic radical nephrectomy.

Authors:  Gagan Gautam; David Lifshitz; Sergey Shikanov; Jocelyn M Moore; Scott E Eggener; Arieh L Shalhav; Anthony Chang
Journal:  J Urol       Date:  2010-09-17       Impact factor: 7.450

6.  Chronic kidney disease due to surgical removal of nephrons: relative rates of progression and survival.

Authors:  Sevag Demirjian; Brian R Lane; Ithaar H Derweesh; Toshio Takagi; Amr Fergany; Steven C Campbell
Journal:  J Urol       Date:  2014-04-18       Impact factor: 7.450

7.  Small renal tumors: correlation of clinical and pathological features with tumor size.

Authors:  Sascha Pahernik; Stefanie Ziegler; Frederik Roos; Sebastian W Melchior; Joachim W Thüroff
Journal:  J Urol       Date:  2007-06-11       Impact factor: 7.450

8.  Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?

Authors:  William C Huang; Elena B Elkin; Andrew S Levey; Thomas L Jang; Paul Russo
Journal:  J Urol       Date:  2008-11-13       Impact factor: 7.450

9.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

10.  Non-neoplastic renal diseases are often unrecognized in adult tumor nephrectomy specimens: a review of 246 cases.

Authors:  Kammi J Henriksen; Shane M Meehan; Anthony Chang
Journal:  Am J Surg Pathol       Date:  2007-11       Impact factor: 6.394

View more
  2 in total

Review 1.  The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma.

Authors:  Susie L Hu; Anthony Chang; Mark A Perazella; Mark D Okusa; Edgar A Jaimes; Robert H Weiss
Journal:  J Am Soc Nephrol       Date:  2016-03-09       Impact factor: 10.121

2.  Cross-Sectional Investigations of Pre- and Post-Operative Renal Global Function and Renal Parenchymal Volumetry in Both Partial and Radical Nephrectomy Utilizing Film-Based Technology.

Authors:  Takehiro Sejima; Tetsuya Yumioka; Noriya Yamaguchi; Toshihiko Masago; Shuichi Morizane; Katsuya Hikita; Masashi Honda; Atsushi Takenaka
Journal:  Curr Urol       Date:  2019-05-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.